NASDAQ 100 Drops 1.97% in February Roll Amid Volatility Spike and Rate Cut Pause

The NASDAQ 100 index shed nearly 2% during the key February 2026 roll period as option premiums declined despite higher VIX levels, signaling shifting market sentiment into Q1 end. US tech-heavy benchmark underperforms broader indices amid uncertainty over 2026 Fed cuts.

The **NASDAQ 100 index** declined 1.97% during the February 2026 roll period from January 16 to February 20, underperforming the S&P 500's 0.33% drop and contrasting the Dow Jones Industrial Average's 0.68% gain.

This pullback marks a shift from the late-2025 rally where the index gained 5.05% from October 29 to November 20, driven by expectations of at least two Fed rate cuts in 2026. The recent softening raises questions on sustained growth momentum for US tech stocks today.

As of: March 24, 2026

Dr. Elena Voss, Senior Tech Equities Analyst. Tracking NASDAQ 100 dynamics through macro and sector lenses for European investors.

Confirmed February Roll Period Losses

Precise data shows the **NASDAQ 100** losing 1.97% net over the 35-day span ending February 20, 2026. This compares to the benchmark's year-end strength, where large-cap growth names propelled total returns above 5%.

Global X ETFs' covered call strategies on the index captured lower premiums at the February roll versus January's levels, with all major US equity covered call funds seeing declines. The smallest January premium was 1.50% for Dow-linked strategies, yet even those outperformed their underlying by 1.19% through the period.

Market breadth narrowed: while the **Dow** eked out gains, tech concentration in the **NASDAQ 100** amplified downside pressure. Recent weekly data confirms ongoing weakness, with Nasdaq Composite down 1.8% last week versus S&P 500's 2.6% drop.

This is not broad-based US equity selling but selective pressure on growth valuations, where **NASDAQ 100** components dominate AI, cloud, and semis exposure.

Volatility Trajectory Drove Premium Compression

VIX closed at 17.14 on February 20, up from 14.54 on January 16, yet call option demand weakened markedly. The Cboe Equity Put/Call Ratio hit 0.64, trending higher and reflecting put protection buying over bullish calls.

January saw VIX rising from a December 24 low of 13.47; February traced down from a February 16 peak of 21.20. This reversal in volatility path crushed premiums despite elevated levels, hurting income strategies tied to **NASDAQ 100** futures and ETFs.

For **Nasdaq 100 today**, this implies thinner buffers for downside in covered call vehicles like Global X offerings. Outperformance narrowed as underlying index losses outpaced premium capture.

European investors note: similar dynamics hit DAX tech names and Swiss semiconductor proxies, with eurozone PMI data due March 24 amplifying cross-Atlantic risk-off flows.

Post-Rally Correction After 2025 Peaks

Recall the setup: an October-November 2025 dip dethroned **NASDAQ 100** all-time highs, followed by a sharp rebound into year-end on Fed cut bets. Early 2026 held the uptrend briefly, but February rolls exposed cracks.

Bitcoin's parallel 25%+ drop from January 16 to February 20 underscores risk-asset repricing, with crypto-covered calls still outperforming by 3.73% via 7.85% premiums. **NASDAQ 100** lacks such yield cushions, making pure equity exposure more volatile.

Historical Nasdaq Composite data through mid-March shows choppy action around 21,000-22,000, with daily swings of 1-2%. No recovery to February lows yet, per available records.

Why now? Markets digest fewer 2026 cuts amid sticky inflation signals, pressuring rate-sensitive **US tech stocks today**.

Implications for NASDAQ 100 Futures and ETFs

**Nasdaq 100 futures** for June 2026 trade with markets pricing levels around 24,400 as a median expectation on prediction platforms, with 69% odds above 24,400. This embeds rebound hopes but reflects current caution.

ETFs tracking the index face outflows in risk-off phases, unlike covered call variants that buffered losses. Global X notes year-to-date fixed income outperformance, up 2.61% vs bonds' 1.20%, but equity pure-plays lag.

Index-level relevance: **NASDAQ 100** weightings amplify moves in megacaps like semiconductors and AI leaders. February's decline was concentrated, not broad-based across all 100 components.

DACH context: ASML and Infineon track **NASDAQ 100** semis closely; a prolonged pullback risks European tech underperformance versus ECB policy divergence.

Macro Catalysts Ahead: Yields, Dollar, and PMIs

No fresh US jobs or inflation prints dominate, but upcoming Germany/UK flash PMIs on March 24 could sway global risk appetite. Weak eurozone data typically boosts USD strength, hurting **NASDAQ 100** multinationals' forex lines.

Treasury yields: implied higher-for-longer rates erode growth stock multiples central to the index. Fed cut expectations from late 2025 have dialed back, per roll-period sentiment.

**S&P 500 vs NASDAQ 100 today**: Tech out/underperforms in rotations; recent week saw Nasdaq -1.8% vs S&P -2.6%, hinting defensive shift. Versus Dow -2.4%, **NASDAQ 100** held relatively firm but trails value.

AI/semiconductor trends: no specific earnings trigger, but theme momentum cooled with premiums, signaling valuation pauses.

Risks and Positioning for European Investors

Confirmed fact: **NASDAQ 100 latest** trades in a 21,000-22,500 Nasdaq Composite range per historicals, post-February weakness. Interpretation: range-bound until PMI/Fed clarity.

Risks include VIX re-spiking above 20, compressing further; upside if cuts reprice lower. ETFs like QQQ see volume spikes in volatility.

For English-speaking DACH investors: time zone overlap aids US open trading; euro weakness aids exporters but hurts importers in index. Spillover to STOXX Europe 600 Tech evident in correlated drawdowns.

Positioning: covered calls offer yield in sideways markets; pure longs vulnerable to rotation.

Outlook: Watch March 24 PMIs for **Nasdaq 100 today** direction; sustained VIX above 17 pressures growth. European angles heighten with ECB-Fed spread.

Disclaimer: Not investment advice. Indices, equities, and other financial instruments are volatile.